To the Editor.—
Levamisole hydrochloride, an antihelminthic, has been reported as a successful method for treating resistant warts.1 In view of the difficulty of treating some patients with persistent recurring warts, it seemed worthy to further pursue the evaluation of levamisole for this indication. Ten patients from my private practice who have a Response to Levamisole No. of Warts No. of PretreatWarts Patient ment Posttreatment 15 1 13 22 16 15 10 20 history of chronic, resistant warts were entered into the study. However, two were lost to follow-up and were therefore deleted from all tabulations and analyses. Of the remaining eight patients, four were male and four were female. The ages ranged from 7 to 57 years.Each patient was instructed to take 150 mg of levamisole hydrochloride on two consecutive days a week. The patients were treated for periods up to seven months. Of the eight
Sutton JD. Report on Levamisole Hydrochloride for Warts. Arch Dermatol. 1977;113(4):521. doi:10.1001/archderm.1977.01640040129029
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: